CD274 and neoplasm: PD-L1 expression has been found positive in 5–40% tumor cells (Xie et al., 2016; Xiang et al., 2018), helping them to dodge the immune elimination through interaction of PD-L1 on the surface of cancer cells with PD-1 on T cells (Topalian et al., 2015).